Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2026 Feb;8(2):e70144.
doi: 10.1002/acr2.70144.

Discordance Between Patients and Physicians on Key Determinants of Systemic Lupus Erythematosus Burden: Insights From a French Comprehensive Survey

Affiliations

Discordance Between Patients and Physicians on Key Determinants of Systemic Lupus Erythematosus Burden: Insights From a French Comprehensive Survey

Laurent Chiche et al. ACR Open Rheumatol. 2026 Feb.

Abstract

Objective: To assess differences in perception between patients and physicians regarding the determinants of the burden of systemic lupus erythematosus (SLE) in France.

Methods: An online survey was conducted by IPSOS, a market research company, among adult patients with SLE and physicians (internists, rheumatologists, nephrologists, and dermatologists) involved in SLE care. The questionnaires were designed by a committee of lupus experts and patient research partners to cover key areas: symptoms experienced by patients with SLE, social and economic impact of the disease, and needs and expectations for the improvement of care pathways. Most questions were formulated to assess comparatively how they were perceived by patients and physicians.

Results: Responses from 107 patients and 101 physicians were analyzed. Regarding experienced symptoms, a patient-physician discordance was observed on the number of reported symptoms (P < 0.001) and in terms of prioritization, especially with the impact of extreme fatigue (76% vs 51%; P < 0.001) and anxiety and depression (45% vs 13%; P < 0.001), even outside flare-up periods. Physicians rarely reported that SLE significantly impacts all areas of their patients' lives, including physical, psychological, social, professional, sexual, and emotional aspects, whereas most patients expressed a lack of medical advice on areas such as sexual and emotional health, family life, professional life, and anxiety. Most patients also declared a perceived lack of information about treatment adverse effects, available therapeutic options, and potential causes of SLE.

Conclusion: This survey highlights the significant patient-physician discordances about the burden of SLE in France and supports the need for specific interventions to improve patient information and holistic care.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Topics addressed by physicians according to patients vs physicians. Statistical comparison of patients and physicians focused on the “very often” modality using chi‐square analysis.
Figure 2
Figure 2
Perception of information provided during consultations. Statistical comparison of patients and physicians focused on the “at each consultation” modality using chi‐square analysis. TPE, therapeutic patient education.

References

    1. Cornet A, Andersen J, Myllys K, et al. Living with systemic lupus erythematosus in 2020: a European patient survey. Lupus Sci Med 2021;8(1):e000469. - PMC - PubMed
    1. Pouchot J, Mandereau‐Bruno L, Serra D, et al. Prevalence, sociodemographic characteristics and spatial distribution of systemic lupus erythematosus in France: a nationwide study using health claims data with insights into hydroxychloroquine prescription patterns. Lupus Sci Med 2025;12(2):e001519. - PMC - PubMed
    1. Meunier B, Jourde‐Chiche N, Mancini J, et al. Characteristics and information searched for by French patients with systemic lupus erythematosus: a web‐community data‐driven online survey. Lupus 2016;25(4):370–375. - PubMed
    1. Scherlinger M, Kolios AGA, Kyttaris VC, et al. Advances in the treatment of systemic lupus erythematosus. Nat Rev Drug Discov 2025;24(12):926–944. - PubMed
    1. Arnaud L, Fabry‐Vendrand C, Todea R, et al. Real‐world oral glucocorticoid use in systemic lupus erythematosus: a nation‐wide population‐based study using the French national medico‐administrative database (LUPIN‐F study). Ann Rheum Dis 2023;82(suppl 1):30.

Grants and funding

LinkOut - more resources